Opioid Use Disorder News
Latest articles and news about Opioid Use Disorder on AXL Media.
Latest Articles
- Large-Scale Medicaid Study Finds Prenatal Buprenorphine Exposure Does Not Increase Long-Term Neurodevelopmental Risks
Published: Apr 18, 2026
Section: Medical News
A comprehensive analysis of 2.5 million US births published in The BMJ concludes that children exposed to buprenorphine in utero face no higher risk of autism, ADHD, or speech diso...
- Buprenorphine Treatment for Pregnant Women Linked to Superior Infant Outcomes and Stable Long-Term Child Development
Published: Apr 16, 2026
Section: Medical News
A comprehensive longitudinal study led by Harvard University and Stanford Medicine researchers has found that buprenorphine provides better neonatal health outcomes than methadone...
- Rutgers Study Finds Recent Medicaid Expansions Drastically Improved National Access to Opioid Addiction Medication
Published: Apr 7, 2026
Section: Medical News
A new analysis by Rutgers Health researchers reveals that Medicaid expansions implemented between 2017 and 2023 significantly boosted the use of buprenorphine for treating opioid u...
- NIH Researchers Identify Novel "Superagonist" Opioid DFNZ with High Potency and Reduced Addiction Risk
Published: Apr 2, 2026
Section: Medical News
Scientists at the National Institutes of Health have discovered DFNZ, a synthetic opioid metabolite that provides robust pain relief in animal models without causing the life-threa...
- Clinical Trial Reveals Weekly Buprenorphine Injections Significantly Outperform Daily Sublingual Doses for Pregnant Patients Seeking Opioid Abstinence
Published: Mar 17, 2026
Section: Science & Tech
A National Institutes of Health study indicates that extended-release buprenorphine injections provide superior illicit opioid abstinence rates during pregnancy compared to traditi...
- NIH Clinical Trial Validates Weekly Injectable Buprenorphine as Superior Treatment for Opioid Use Disorder During Pregnancy
Published: Mar 16, 2026
Section: Science & Tech
A landmark study funded by the National Institutes of Health has found that weekly extended-release buprenorphine injections are more effective at maintaining illicit opioid abstin...